|
| |
|
P: POSTER SESSION |
EXHIBITION HALL |
|
COLCHICINE IN TEARS OF PATIENTS WITH FAMILIAL
MEDITERRANEAN FEVER
Y. Alster, J.M. Scherrmann, B. Azmon, I.S. Barequet, A. Livneh, T.P. O'Brien, M. Lazar,
Tel Aviv, Israel |
|
|
THE EFFECTS OF INTRAOCULAR PRESSURE AND
ANALYSIS OF DRUG PATHWAY TOPICALLY APPLIED CARTEOLOL IN PIGMENTED AND ALBINO RABBITS
Y. Aoyama, N. Fujio, M. Hashimoto, S. Ueno, Kawasaki, Japan |
|
|
OCULAR PENETRATION OF SDZ GLC 756, A MIXED
DOPAMINE D-1 RECEPTOR ANTAGONIST AND DOPAMINE D-2 RECEPTOR AGONIST, ADMINISTERED BY USING
TRANSCLERAL IONTOPHORESIS IN RABBITS
M. Babiole, C. Debon, C.L. Percicot, G.N. Lambrou, F. Behar-Cohen, Basel, Switzerland |
|
|
INFLUENCE OF PHYSICOCHEMICAL AND
PHARMACOLOGICAL PROPERTIES ON TRANSCORNEAL PERMEABILITY THROUGH PIG CORNEAS IN VITRO
M. Babiole, F. Wilhelm, B. Faller, G.N. Lambrou, R. Markstein, Basel, Switzerland |
|
|
SELECTION OF BIODEGRADABLE DEXAMETHASONE MICROSPHERES DESTINED TO
INTRAVITREAL ADMINISTRATION FROM A FACTORIAL DESIGN
C. Alvarez, E. Barcia, S. Negro, R. Herrero-Vanrell, A. Diez, M.I. Lopez, M Calonge,
Madrid, Spain |
|
|
THE USE OF EIKONOL PREPARATION IN PATIENTS
WITH DIABETIC RETINOPATHY
M.I. Beliaeva, V.A. Isaev, Moscow, Russia |
|
|
ENZYMOTHERAPY IN HEMOPHTHALMIA IN PATIENTS
WITH DIABETIC RETINOPATHY
M.I. Beliaeva, A.V. Bolshunov, G.S. Polunin, D.V. Andjelova, Moscow, Russia |
|
|
COMPARATIVE IN VITRO ACTIVITY OF AZITHROMYCIN, CLARITHROMYCIN AND
ERYTHROMYCIN AGAINST CONTEMPORARY CLINICAL OCULAR ISOLATES
A.R. Blanco, M. Cannatelli, S. Cufari, A. Asero, Catania, Italy |
|
|
APOPTOSIS AND NON-STEROIDAL ANTI-INFLAMMATORY
DRUGS TREATMENT
A. Bulboaca, A. Bulboaca, R. Pop, Cluj-Napoca, Romania |
|
|
DEVELOPMENT
OF A RABBIT MODEL OF PANUVEITIS SUITABLE FOR PHARMACOLOGIC INHIBITION
A. Diez, M. Calonge, C. Alvarez, M.I. Lopez, R. Herrero, Valladolid, Spain |
|
|
COMPARISON OF THE INTRAOCULAR PRESSURE-LOWERING EFFECT OF LATANOPROST
MONOTHERAPY TO PILOCARPINE OR DORZOLAMIDE AS ADJUNCTIVE THERAPY TO TIMOLOL
R. Ciappetta, P. Frezzotti, Siena, Italy |
|
|
ANTIANGIOGENESIS BY CYCLOSPORINE-A (CsA) IN EXUDATIVE AGE-RELATED MACULAR
DEGENERATION (ARMD)
G. Durante, R. Dammacco, T.M. Ferrari, M. Vetrugno, L. Cardia, Bari, Italy |
|
|
LOW VISCOSITY HYDROGELS BASED ON CHITOSAN FOR THE TREATMENT OF
KERATOCONJUNCTIVITIS SICCA
O. Felt, A. Carrel, P. Baehni, P. Buri, R. Gurny, Geneva, Switzerland |
|
|
EFFECT OF LATANOPROST ALONE AND IN ADDITION TO TIMOLOL ON INTRAOCULAR
PRESSURE IN GLAUCOMATOUS EYES
P. Prezzotti, R. Ciappetta, Siena, Italy |
|
|
TISSUE SPECIFIC CALPAINS IN THE EYE
C. Fukiage, H. Ma, T. Nakajima, M. Azuma, T.R. Shearer, Portland, Or, USA |
|
|
NATURAL TEAR SUBSTITUTES FOR SEVERELY DRY
EYES
G. Geerling, A. Poon, J.T. Daniels, L.A. Cree, J.K.G. Dart, London, UK |
|
|
RANDOMISED CONTROLLED TRIAL OF KETOROLAC IN
THE MANAGEMENT OF CORNEAL ABRASIONS
R. Goyal, J. Shankar, D.L. Fone, D.S. Hughes, Newport, UK |
|
|
EFFECTS
OF ALLOPURINOL AFTER TOPICAL APPLICATION ON IgG AND IgA ANTIBODIES IN
UVEITIS
F.H. Grus, A.J. Augustin, K.U. Loeffler, Mainz, Germany |
|
|
USE OF OZONE IN THE TREATMENT OF EYE
INFECTIONS
R.A. Gundorova, V.P. Bykov, M.G. Gogodze, Moscow, Russia |
|
|
ACUVUEŽ CONTACT LENSES IMPROVE THE
PENETRATION OF TOPICALLY APPLIED ANTIBIOTICS INTO AQUEOUS HUMOUR
E.-M. Hehl, R. Beck, R. Guthoff, B. Drewelow, Rostock, Germany |
|
|
OCULAR BIOAVAILABILITY IMPROVED BY COMPUTER
SIMULATION
M. Higashiyama, K. Inada, A. Ohtori, K. Tojo, Kobe, Japan |
|
|
BROMFENAC SAFETY TO LIVER: A CASE FOR
OPHTHALMIC
ADMINISTRATION
M. Isaka, A. Sumida, K. Takahashi, J. Azuma, Kobe, Japan |
|
|
SOME PECULARITIES OF DIAGNOSTIC DRY EYE
DURING THE CONDUCTING OF PHOTOREFRACTIVE OPERATIONS. INFLUENCE LASIK ON CONCENTRATION OF
K+
V.V. Kourenkov, V.M. Sheludchenko, G.S. Polunin, O.A. Kachnikova, Moscow, Russia |
|
|
ACUPUNCTURE FOR PATIENTS WITH
OCULAR HYPERTENSION
S.N. Kurtz, R. Tsur, B. Azmon, A. Lowenstein, Tel Aviv, Israel |
|
|
RETINAL TOXICITY OF GENTAMYCIN AFTER SUBCONJUCTIVAL INJECTION PERFORMED
ADJACENT TO THINNED SCLERA
A. Loewenstein, E. Zemel, M. Lazar, I. Perlman, Tel Aviv, Israel |
|
|
THE DEVELOPING RABIT RETINA IS PROTECTED FROM GENTAMYCIN TOXICITY
A. Loewenstein, E. Zemel, M. Lazar, I. Perlman, Tel Aviv, Israel |
|
|
CYCLODEXTRINS AS DRUG DELIVERY SYSTEMS IN OPHTHALMOLOGY
T. Loftsson, E. Stefansson, Reykjavik, Iceland |
|
|
STABILITY STUDY OF CHAMOMILE OPHTHALMIC SOLUTION (Matricaria recutita)
I. Lopez S., R.M. Tornero, G.P. Cuevas, Guadalajara, Mexico |
|
|
FIBRINOLYTIC EFFECT OF GEMAZAŽ ON LYSIS OF
FIBRIN SYMPTOMS OF THE IRITIS AFTER CATARACT EXTRACTION
I.A. Makarov, S.I. Varnakov, G.S. Pounin, V.E. Bocharov, Moscow, Russia |
|
|
LACTOFERRIN EFFICACY IN RE-EPITHELIALIZATION: A SEM STUDY
M.G. Mazzone, C. Marino, A.R. Blanco, M. Marrano, F. Trombetta, V. Enea, Catania, Italy |
|
|
BICHEMICAL CONTROL IN ACETAZOLAMIDE THERAPY
An. Nakowa, Ek. Nakova, Ek. Tasseva, Sofia, Bulgaria |
|
|
VISUAL FIELD CONSTRICTION AS A SIDE EFFECT OF
GABA-MIMETIC ANTIEPILEPTIC AGENTS
J-P. Nordmann, F. Brion, L. Mansuy, Paris, France |
|
|
IN VITRO EFFECTIVENESS OF A VISCOELASTIC
SUBSTANCE DURING A SIMULATED INTRAOCULAR SURGERY: A COMPARATIVE STUDY
E. Lopez-Chavez, M. Padilla-Morones, P. Munoz-Rodriguez, Guadalajara, Mexico |
|
|
OCULAR TOLERANCE OF TWO DIFFERENT
FORMULATIONS OF 0.05% AZELASTINE HYDROCHLORIDE: A COMPARATIVE CLINICAL TRIAL
M. Padilla-Morones, E. Lopez-Chavez, Guadalajara, Mexico |
|
|
A COMPARISON OF THE OCULAR TOLERANCE OF TWO DIFFERENT FORMULATIONS OF
0.05% AZELASTINE HYDROCHLORIDE AND A PLACEBO IN HEALTHY VOLUNTEERS
M. Padilla-Morones, E. Lopez-Chavez, Guadalajara, Mexico |
|
|
EFFICACY, SAFETY AND TOLERANCE OF A NEW CHAMOMILE OPHTHALMIC SOLUTION
M. Padilla-Morones, E. Lopez-Chavez, Guadalajara, Mexico |
|
|
HYALURONIC ACID 0.4% PRESERVATIVE FREE, AN HUMECTANT FOR THE TREATMENT OF
DRY EYE: A COMPARATIVE CLINICAL TRIAL OF SAFETY AND EFFICACY vs POLYACRYLIC ACID 0.2%
LIQUID GEL
O. Garza-Saide, L.A. Lozano-Lopez, M. Padilla-Morones, E. Lopez-Chavez, Guadalajara,
Mexico |
|
|
SAFETY STUDY OF A NEW INTRAOCULAR IMPLANT OF CIPROFLOXACIN TO PREVENT
INFECTION AFTER CATARACT SURGERY
G. Avalos-Urzua, E. Lopez-Chavez, M. Padilla-Morones, I. Ferreira-Vargas, Guadalajara,
Mexico |
|
|
DEXAMETHASONE INTRAOCULAR IMPLANT AND CIPROFLOXACIN INTRAOCULAR IMPLANT
FOR CATARACT SURGERY: A SAFETY STUDY
H. Sayavedra-Madrigal, E. Lopez-Chavez, M. Padilla-Morones, Guadalajara, Mexico |
|
|
SAFETY OF A DEXAMETHASONE INTRAOCULAR IMPLANT TOGETHER WITH A
CIPROFLOXACIN INTRAOCULAR IMPLANT AFTER CATARACT PHACOEMULSIFICATION
P. Gomez-Bastar, D. Juarez-Cosmes, A. Vargas-Luna, H. Luna-Victoria, M. Padilla-Morones,
E. Lopez-Chavez, Guadalajara, Mexico |
|
|
SAFETY AND EFFICACY OF HYALURONIC ACID 0.4% PRESERVATIVE FREE vs
POLYACRYLIC ACID 0.2% LIQUID GEL AFTER LASIK
R. Suarez-Sanchez, A. Gomez-Bastar, M. Padilla-Morones, E. Lopez-Chavez, Guadalajara,
Mexico |
|
|
SAFETY AND EFFICACY OF AN OPHTHALMIC SOLUTION
OF TOBRAMYCIN AND DICLOFENAC IN BACTERIAL CONJUNCTIVITIS: A COMPARATIVE CLINICAL TRIAL
A. Climent, O. Garza, P. Gomez, J. Flores, H. Sayavedra, H. Margueli, M. Padilla-Morones,
E. Lopez-Chavez, Guadalajara, Mexico |
|
|
STRATEGIES IN THE SYATEMIC TREATMENT OF
OCULAR CICATRICIAL PEMPHIGOID
A. Ramsay, London, UK |
|
|
OCULAR CONTACT TIME OF A CARBOMER-BASED
SOLUTION IN HUMANS
S. Rao, C. Richard, C. Trinquand, C. Wilson, Montpellier, France |
|
|
A SAFETY AND HYPOTENSIVE EFFICACY OF
TREATMENT WITH TIMOLOL SUBLINGUAL TABLETS IN GLAUCOMA PATIENTS
J. Toczolwski, R. Rejdak, Lublin, Poland |
|
|
EFFICACY OF TOPICAL 0.05% MEQUITAZINE IN
CONJUNCTIVAL PROVOCATION TESTS
C. Richard, C. Trinquand, Montpellier, France |
|
|
LEVOFLOXACIN PLASMA CONCENTRATIONS FOLLOWING
ADMINISTRATION OF 0.5% LEVOFLOXACIN OPHTHALMIC SOLUTION IN HEALTHY VOLUNTEERS
M.A. Rinehart, A.L. Laurent, J.A. Hutcheson, A.L. Graves, Napa, CA, USA |
|
|
REDUCTION OF LIPID PEROXIDATION FROM RETINA AND LENS OF RABBITS USING
PHENYLBUTAZONE SOLVED IN SILICONE OIL (SO)
E. Rodriguez de la Rua, E. Zamarron, B. Carrasco, J.A. Aragon, P. Marinero, J.C. Pastor,
Valladolid, Spain |
|
|
VISITON - VISCOELASTIC WITH BIOLOGICAL ACTIVE COMPONENTS
I.A. Maklakova, S.N. Bagrov, T.I. Ronkina, B.E. Malyugin, N.S. Khojayev, Moscow, Russia |
|
|
SULFATED GLYCOSAMINOGLYCANS (sGAGs) - PROLIFERATION ACTIVATORS OF CORNEAL
ENDOTHELIAL CELLS AND KERATOCYTES
T.I. Ronkina, S.N. Bagrov, A.V. Zolotorevsky, I.A. Maklakova, S.V. Novikov, I.A.
Zakharova, Moscow, Russia |
|
|
PROTECTION BY A CALPAIN INHIBITOR OF NEURONAL
CELLS FROM ISCHEMIC INJURY IN RETINA
Y. Sakamoto, M. Nakamura, Y. Tamada, O. Sakai, Y. Kawamoto, J. Inoue, Y. Yoshida, M.
Azuma, Kobe, Japan |
|
|
DRUG PERMEATION THROUGH ISOLATED PIG CORNEA
AFTER REMOVING DIFFERENT AMOUNTS OF EPITHELIUM WITH THE EXCIMER LASER
M. Scholz, S. Schrunder, U. Pleyer, S. Keipert, Berlin, Germany |
|
|
THE EFFECT OF DEXTROMETHORPHAN TREATMENT ON LASER-INDUCED RETINAL INJURIES
IN RATS
M. Rosner, I. Ben-Bassat, Y. Solberg, G. Dubinski, M. Belkin, Tel Aviv, Israel |
|
|
EFFECTS OF A FIXED COMBINATION
OF TIMOLOL AND DORZOLAMIDE ON OCULAR HYPERTENSION
L. Taverniti, L. Arrico, S. Di Staso, S.M. Recupero, Rome, Italy |
|
|
SIMULATED USE TEST OF MULTIDOSE CHAMOMILE OPHTHALMIC
SOLUTION (Matricaria recutita)
I.S. Lopez, M.R. Tornero, G.P. Cuevas, Guadalajara, Mexico |
|
|
EFFICACY OF ANTIMICROBIAL PRESERVATION OF
MULTIDOSE CHAMOMILE OPHTHALMIC SOLUTION (Matricaria recutita)
I.S. Lopez, R.M. Tornero, G.P. Cuevas, Guadalajara, Mexico |
|
|
STABILITY STUDY OF SODIUM DICLOFENAC
OPHTHALMIC SOLUTION WITH DIFFERENT PRESERVATIVES
I. Lopez, P. Rodriguez, C. Gutierrez, E. Cruz, R. Tornero, G. Cuevas, Guadalajara, Mexico |
|
|
TOLERANCE OF 0.05% MEQUITAZINE EYE DROPS
C. Trinquand, C. Richard, Montpellier, France |
|
|
EFFECT OF VITAMIN E ON LIPID HYDROPEROXIDE-INDUCED CORNEAL
NEOVASCULARIZATION.
T.N. Ueda, A. Higa, Y. Arai, S. Fukuda, T. Ueda, D. Armstrong, Tokyo, Japan |
|
|
SAFETY OF MICROESPHERES LOADED WITH CYCLOSPORIN A (MICRO-CYA) IN THE
PREVENTION OF CORNEAL GRAFT REJECTION
A.I. Vallelado, M.I. Lopez, M. Calonge, A. Sanchez, M.J. Alonso, Valladolid, Spain |
|
|
EFFICACY AND SAFETY OF 0.5% LEVOFLOXACIN OPHTHALMIC SOLUTION (LVFX) IN A
PEDIATRIC POPULATION
A.L. Van Buskirk, S.J. Lichtenstein, A.L. Graves, M.A. Rinehart, Napa, CA, USA |
|
|
RHO-KINASE INHIBITOR, Y-27632, AS A POSSIBLE ANTI-GLAUCOMATOUS DRUG
M. Waki, Y. Sakamoto, Y. Yoshida, M. Azuma, Kobe, Japan |
|
|
HUMAN CONNECTIVE TISSUE GROWTH FACTOR MRNA
EXPRESSION IN LENS EPITHELIAL CELLS DURING THE FORMATION OF ANTERIOR SUBCAPSULAR CATARACT
AND POSTERIOR CAPSULE OPACIFICATION
K. Wunderlich, M. Pech, A. Eberle, M. Mihatsch, J. Flammer, P. Meyer, Basel, Switzerland |
|
|
STAUROSPORINE-INDUCED
APOPTOSIS IN HUMAN CORNEA EPITHELIAL CELLS IN VITRO
M. Zorn-Kruppa, S. Tykhonova, S. Hartel, M. Engelke, H.A. Diehl, Bremen, Germany |
|
|
AN OCULAR MELANOMA MURINE MODEL SYSTEM FOR
LIVER METASTASIS
D, Rusciano, E.C. Diaz, S. Dithmar, M.J. Lynn, D.H. Lawson,
H.S.Grossniklaus, Basel, Switzerland |
|
|
